110 related articles for article (PubMed ID: 20926473)
1. Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis.
Yilmaz Y; Yonal O; Kurt R; Ari F; Oral AY; Celikel CA; Korkmaz S; Ulukaya E; Ozdogan O; Imeryuz N; Avsar E; Kalayci C
Ann Clin Biochem; 2010 Nov; 47(Pt 6):549-53. PubMed ID: 20926473
[TBL] [Abstract][Full Text] [Related]
2. Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores.
Kalabay L; Gráf L; Vörös K; Jakab L; Benko Z; Telegdy L; Fekete B; Prohászka Z; Füst G
BMC Gastroenterol; 2007 Mar; 7():15. PubMed ID: 17394649
[TBL] [Abstract][Full Text] [Related]
3. Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease.
Colak Y; Senates E; Ozturk O; Yilmaz Y; Coskunpinar E; Kahraman OT; Sahin O; Zemheri E; Enc FY; Ulasoglu C; Kiziltas S; Kurdas OO; Tuncer I
Hepatogastroenterology; 2011; 58(112):2087-90. PubMed ID: 22024080
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.
Suzuki A; Angulo P; Lymp J; Li D; Satomura S; Lindor K
Liver Int; 2005 Aug; 25(4):779-86. PubMed ID: 15998429
[TBL] [Abstract][Full Text] [Related]
5. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
7. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
8. Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.
Yilmaz Y; Eren F; Yonal O; Kurt R; Aktas B; Celikel CA; Ozdogan O; Imeryuz N; Kalayci C; Avsar E
Eur J Clin Invest; 2010 Oct; 40(10):887-92. PubMed ID: 20624171
[TBL] [Abstract][Full Text] [Related]
9. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.
Adams LA; Angulo P
Clin Liver Dis; 2007 Feb; 11(1):25-35, viii. PubMed ID: 17544970
[TBL] [Abstract][Full Text] [Related]
10. Human fetuin/alpha2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer.
Kalabay L; Jakab L; Prohászka Z; Füst G; Benkö Z; Telegdy L; Lörincz Z; Závodszky P; Arnaud P; Fekete B
Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):389-94. PubMed ID: 11943951
[TBL] [Abstract][Full Text] [Related]
11. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
12. Plasma interleukin-18/interleukin-18 binding protein ratio in Chinese with NAFLD.
Li Y; Li-Li Z; Qin L; Ying W
Hepatogastroenterology; 2010; 57(97):103-6. PubMed ID: 20422882
[TBL] [Abstract][Full Text] [Related]
13. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.
Targher G; Bertolini L; Scala L; Cigolini M; Zenari L; Falezza G; Arcaro G
Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):517-24. PubMed ID: 16928437
[TBL] [Abstract][Full Text] [Related]
14. [Taurine in the treatment of non-alcoholic fatty liver disease].
Zvenigorodskaia LA; Ovsiannikova ON; Noskova KK; Nilova TV; Elizarova EP
Eksp Klin Gastroenterol; 2010; (7):43-50. PubMed ID: 21033082
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
Kaneda H; Hashimoto E; Yatsuji S; Tokushige K; Shiratori K
J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease.
Calès P; Boursier J; Chaigneau J; Lainé F; Sandrini J; Michalak S; Hubert I; Dib N; Oberti F; Bertrais S; Hunault G; Cavaro-Ménard C; Gallois Y; Deugnier Y; Rousselet MC
Liver Int; 2010 Oct; 30(9):1346-54. PubMed ID: 20666992
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
[TBL] [Abstract][Full Text] [Related]
18. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis.
Manco M; Bedogni G; Marcellini M; Devito R; Ciampalini P; Sartorelli MR; Comparcola D; Piemonte F; Nobili V
Gut; 2008 Sep; 57(9):1283-7. PubMed ID: 18218674
[TBL] [Abstract][Full Text] [Related]
19. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis.
Tsang SW; Ng WF; Wu BP; Chow DA; Li ET; Wong TC
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):116-21. PubMed ID: 16706822
[TBL] [Abstract][Full Text] [Related]
20. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
